Safety and Efficacy of Autologous Cell Therapy in Critical Limb Ischemia: A Systematic Review
Author:
Affiliation:
1. Department of Surgery, Tufts Medical Center, Boston, MA, USA
2. The CardioVascular Center, Tufts Medical Center, Boston, MA, USA
3. Division of Cardiothoracic Surgery, University of Utah, Salt Lake City, UT, USA
Abstract
Publisher
SAGE Publications
Subject
Transplantation,Cell Biology,Biomedical Engineering
Link
http://journals.sagepub.com/doi/pdf/10.3727/096368912X636777
Reference73 articles.
1. Autologous Bone Marrow Cell Transplantation Increases Leg Perfusion and Reduces Amputations in Patients with Advanced Critical Limb Ischemia Due to Peripheral Artery Disease
2. Granulocyte Colony-Stimulating Factor A Noninvasive Regeneration Therapy for Treating Atherosclerotic Peripheral Artery Disease
3. Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia
4. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
5. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (The TAM-PAD study)
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Co-Delivery of Bioengineered Exosomes and Oxygen for Treating Critical Limb Ischemia in Diabetic Mice;ACS Nano;2023-12-08
2. DIAGNOSIS AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH DIABETES MELLITUS;Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії;2023-11-03
3. Autologous Bone Marrow Stem Cells in Patients With Critical Limb Ischaemia not Eligible for Revascularization: A Single Centre Experience;Angiology;2023-09-20
4. Autologous Peripheral Blood Mononuclear Cells in Patients with Small Artery Disease and Diabetic Foot Ulcers: Efficacy, Safety, and Economic Evaluation;Journal of Clinical Medicine;2023-06-20
5. Peripheral arterial disease (PAD) – A challenging manifestation of atherosclerosis;Preventive Medicine;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3